Vanda Fights FDA's Refusal To Fast-Track Gastro Drug Review
Vanda Pharmaceuticals says the U.S. Food and Drug Administration tried to rewrite the law when it chose not to streamline review of a drug meant to fight nausea in patients with...To view the full article, register now.
Already a subscriber? Click here to view full article